Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
With an estimated prevalence of 5.8 million in the USA and over 23 million people
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …
[引用][C] Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
S Yandrapalli, G Andries, M Biswas… - Vascular Health and Risk …, 2017 - cir.nii.ac.jp
Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
S Yandrapalli, G Andries… - Vascular health and …, 2017 - pubmed.ncbi.nlm.nih.gov
With an estimated prevalence of 5.8 million in the USA and over 23 million people
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …
Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
S Yandrapalli, G Andries, M Biswas… - Vascular Health and …, 2017 - search.proquest.com
With an estimated prevalence of 5.8 million in the USA and over 23 million people
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …
Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives.
S Yandrapalli, G Andries, M Biswas… - Vascular Health and Risk …, 2017 - europepmc.org
With an estimated prevalence of 5.8 million in the USA and over 23 million people
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …
[HTML][HTML] Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
S Yandrapalli, G Andries, M Biswas… - Vascular Health and …, 2017 - ncbi.nlm.nih.gov
With an estimated prevalence of 5.8 million in the USA and over 23 million people
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …
[PDF][PDF] Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
S Yandrapalli - Vascular Health and Risk Management, 2017 - pdfs.semanticscholar.org
With an estimated prevalence of 5.8 million in the USA and over 23 million people
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …
Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
S Yandrapalli, G Andries, M Biswas… - Vascular Health and Risk …, 2017 - go.gale.com
With an estimated prevalence of 5.8 million in the USA and over 23 million people
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …
Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
S Yandrapalli, G Andries, M Biswas… - Vascular Health and Risk …, 2017 - dovepress.com
With an estimated prevalence of 5.8 million in the USA and over 23 million people
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …
Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
S Yandrapalli, G Andries, M Biswas… - Vascular Health and …, 2017 - dash.harvard.edu
With an estimated prevalence of 5.8 million in the USA and over 23 million people
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …
worldwide, heart failure (HF) is growing in epidemic proportions. Despite the use of …